2004
DOI: 10.1016/j.reprotox.2003.10.007
|View full text |Cite
|
Sign up to set email alerts
|

Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

8
135
1
8

Year Published

2008
2008
2017
2017

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 229 publications
(152 citation statements)
references
References 22 publications
8
135
1
8
Order By: Relevance
“…The rate of major congenital anomalies was compared to that of 790 controls that were counselled for non-teratogenic exposure. There was no case of oral cleft and no pattern of anomalies among the GCs exposed group, supporting the opinion that these hormones do not represent a major teratogenic risk in humans (Gur et al,2004). A survey of the literature concerning 468 pregnant women treated with corticosteroids outside the transplant setting demonstrated an overall malformation rate of 3.5%, thus within the expected incidence in the general population (Danesi & Del Tacca, 2004).…”
Section: Resultssupporting
confidence: 56%
“…The rate of major congenital anomalies was compared to that of 790 controls that were counselled for non-teratogenic exposure. There was no case of oral cleft and no pattern of anomalies among the GCs exposed group, supporting the opinion that these hormones do not represent a major teratogenic risk in humans (Gur et al,2004). A survey of the literature concerning 468 pregnant women treated with corticosteroids outside the transplant setting demonstrated an overall malformation rate of 3.5%, thus within the expected incidence in the general population (Danesi & Del Tacca, 2004).…”
Section: Resultssupporting
confidence: 56%
“…We observed an increased risk of preterm birth associated with both first and subsequent births. Preterm birth has also been associated with the use of prednisone, even in low doses during pregnancy (35,36), and prednisone is a commonly used medication to treat inflammatory active disease in pregnant women with SLE.…”
Section: Discussionmentioning
confidence: 99%
“…They are indicated in moderately to severe cases (1) . Findings of low birth weight and newborns small for gestational age during the use of prednisolone during pregnancy have not been confirmed in more recent studies (25,41,48) . It is classified as Class C for use during pregnancy.…”
Section: B) Corticosteroidsmentioning
confidence: 80%